CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 62 filers reported holding CYTOSORBENTS CORP in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $699 | -47.6% | 372 | 0.0% | 0.00% | – |
| Q2 2023 | $1,335 | +33.5% | 372 | 0.0% | 0.00% | – |
| Q1 2023 | $1,000 | +99900.0% | 372 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 372 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -98.3% | 372 | -98.6% | 0.00% | – |
| Q2 2022 | $59,000 | -6.3% | 26,813 | +36.0% | 0.00% | – |
| Q1 2022 | $63,000 | -79.3% | 19,711 | -72.8% | 0.00% | – |
| Q4 2021 | $304,000 | +141.3% | 72,386 | +364.0% | 0.00% | – |
| Q3 2021 | $126,000 | +3.3% | 15,602 | -3.1% | 0.00% | – |
| Q2 2021 | $122,000 | -10.3% | 16,104 | +2.7% | 0.00% | – |
| Q1 2021 | $136,000 | -6.2% | 15,676 | -13.8% | 0.00% | – |
| Q4 2020 | $145,000 | +16.9% | 18,196 | +18.8% | 0.00% | – |
| Q3 2020 | $124,000 | +7.8% | 15,313 | +32.0% | 0.00% | – |
| Q2 2020 | $115,000 | +51.3% | 11,598 | +18.6% | 0.00% | – |
| Q1 2020 | $76,000 | -51.0% | 9,782 | -75.7% | 0.00% | – |
| Q4 2019 | $155,000 | +210.0% | 40,252 | +301.0% | 0.00% | – |
| Q3 2019 | $50,000 | -10.7% | 10,038 | +19.4% | 0.00% | – |
| Q2 2019 | $56,000 | +1.8% | 8,410 | +15.9% | 0.00% | – |
| Q1 2019 | $55,000 | -32.1% | 7,256 | -28.0% | 0.00% | – |
| Q4 2018 | $81,000 | -93.6% | 10,081 | -89.7% | 0.00% | – |
| Q3 2018 | $1,267,000 | -43.8% | 98,188 | -50.3% | 0.00% | – |
| Q2 2018 | $2,253,000 | +5676.9% | 197,580 | +3193.0% | 0.00% | – |
| Q4 2017 | $39,000 | +1850.0% | 6,000 | +2005.3% | 0.00% | – |
| Q3 2017 | $2,000 | +100.0% | 285 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | -85.7% | 285 | -82.4% | 0.00% | – |
| Q1 2017 | $7,000 | -36.4% | 1,620 | -19.0% | 0.00% | – |
| Q4 2016 | $11,000 | -21.4% | 2,001 | -5.6% | 0.00% | – |
| Q3 2016 | $14,000 | +55.6% | 2,119 | +3.8% | 0.00% | – |
| Q2 2016 | $9,000 | +12.5% | 2,042 | 0.0% | 0.00% | – |
| Q1 2016 | $8,000 | -42.9% | 2,042 | -18.7% | 0.00% | – |
| Q4 2015 | $14,000 | – | 2,511 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $846,000 | 0.90% |
| Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
| Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
| Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
| Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
| Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
| HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
| Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
| Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |